
|Articles|April 1, 1998
- Psychiatric Times Vol 15 No 4
- Volume 15
- Issue 4
Learning the Shapes
Learning the Shapes - Poetry of the Times
Advertisement
Five students
wear short white coats,
pockets bulging notecards,
tuning forks, new stethoscopes.
Demanding consent
we snap on latex gloves,
smear index fingers with K-Y,
turn them over, spread them apart
and enter alone, one by one
to learn the shapes inside:
smooth chestnut, soft orange,
stone in a muddy field.
After wiping off the jelly
we wash our hands clean,
examining fingers sensitive
as a blind bluesman
who hears each note
an instant before
touching a tight steel string.
© CME LLC
4/98
Articles in this issue
over 28 years ago
Inside Outover 28 years ago
Executing the Mentally Illover 28 years ago
SAMHSA Study Uncovers Increasing Substance Abuse Among Young Girlsover 28 years ago
Turf War: Will State Hospital Patients Suffer?over 28 years ago
Is There a Common Basis for All Addictions?over 28 years ago
New Prescription for Paraphilia?over 28 years ago
PTSD in Survivors of Rwanda's 1994 WarAdvertisement
Related to this article

How to interpret antipsychotic drug levels in schizophrenia: when labs mislead, when levels help adherence and toxicity checks, and why serial monitoring matters.

Male athletes with anorexia often go unnoticed as “discipline”; learn red flags, sport-specific risks, health consequences, and treatment steps for earlier diagnosis.

Explore major depression subtypes—from melancholic to inflammatory—and how they shape symptoms, biology, and treatment choices for better outcomes.

Therapeutic drug monitoring takes guesswork out of antipsychotic care—spotting nonadherence, guiding dose targets, and defining response thresholds and the “point of futility” in schizophrenia.

A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.

TRD often mislabels depression; learn why MDD heterogeneity demands tailored treatments and when “difficult-to-treat” fits better.

First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.
Advertisement
Advertisement

